AQST - Aquestive Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AQST (1398733)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
19 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2019-08-27
AQSTBarber DanielSVP-COOP - Purchase$3.99+2,000101,959+2%+$7,980
M
2019-08-19
AQSTScibetta James SDirP - Purchase$3.79+22,97131,635+265%+$86,977
M
2019-08-09
AQSTKendall Keith JCEO, PresP - Purchase$3.87+8,000654,581+1%+$30,987
2019-08-09
AQSTWood TheresaSVP-HR, Org. DevelopmentP - Purchase$3.99+1,00080,765+1%+$3,990
2019-08-09
AQSTBraender Lori JSVP, GCP - Purchase$4.07+10,00011,000>999%+$40,747
2019-08-12
AQSTBoyd Peter E.SVP-Bus. Process, Info. Tech.P - Purchase$3.81+60050,239+1%+$2,286
2018-12-10
AQSTSchobel Alexander MarkChief Innovation, Tech OfficerP - Purchase$7.78+1,0001,019,6240%+$7,780
2018-12-06
AQSTSchobel Alexander MarkChief Innovation, Tech OfficerP - Purchase$8.69+2,0001,018,6240%+$17,380
2018-12-10
AQSTBarber DanielSVP-Chief Strategy, Dev OfficeP - Purchase$8.00+1,00099,959+1%+$8,000
2018-12-06
AQSTMaxwell John T.SVP-CFOP - Purchase$8.87+5,000153,614+3%+$44,350
2018-11-21
AQSTMarshall Ken W.Commercial LeaderP - Purchase$10.15+1,4451,445New+$14,667
2018-11-27
AQSTBraender Lori JGCP - Purchase$10.57+1,0001,000New+$10,570
2018-11-27
AQSTKendall Keith JCEO, PresP - Purchase$9.87+1,000621,1390%+$9,870
2018-11-26
AQSTWood TheresaSVP-HR, Org. DevelopmentP - Purchase$10.34+50079,765+1%+$5,170
2018-11-21
AQSTSchobel Alexander MarkChief Innovation, Tech OfficerP - Purchase$10.25+1,0001,009,2290%+$10,250
2018-11-21
AQSTMaxwell John T.SVP-CFOP - Purchase$9.80+10,000148,614+7%+$98,000
M
2018-11-21
AQSTKendall Keith JCEO, PresP - Purchase$10.10+7,950620,139+1%+$80,325
2018-11-21
AQSTBoyd Peter E.SVP-Operations, Value DeliveryP - Purchase$9.98+20049,6390%+$1,996
2018-07-24
AQSTBratton Douglas KDir, 10%P - Purchase$15.00+165,00011,578,379+1%+$2,475,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top